Fennec Pharmaceuticals Inc. (FENC)
NASDAQ·Healthcare·Biotechnology
$6.73
-1.75%
Mkt Cap $209.10M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | $14.67M | $13.81M | -5.83% | $0.03 | -$0.11 | -466.67% | — | — |
| Q4 2025 Nov 13, 2025 | $14.69M | $12.46M | -15.16% | -$0.08 | -$0.02 | +75.00% | — | — |
| Q3 2025 Aug 14, 2025 | $9.56M | $9.65M | +0.94% | -$0.06 | -$0.11 | -83.33% | — | — |
| Q2 2025 May 13, 2025 | $9.04M | $8.75M | -3.23% | -$0.12 | -$0.04 | +66.67% | — | — |
| Q1 2025 Mar 10, 2025 | $7.80M | $7.92M | +1.59% | $0.56 | -$0.06 | -110.71% | — | — |
| Q4 2024 Nov 7, 2024 | $8.01M | $6.97M | -12.93% | -$0.13 | -$0.21 | -61.54% | — | — |
| Q3 2024 Aug 13, 2024 | $11.05M | $7.26M | -34.28% | $0.06 | -$0.20 | -433.33% | — | — |
| Q2 2024 May 14, 2024 | $18.88M | $25.38M | +34.41% | $0.26 | $0.47 | +80.77% | — | — |
| Q1 2024 Mar 21, 2024 | $8.67M | $9.73M | +12.28% | -$0.02 | -$0.10 | -400.00% | — | — |
| Q4 2023 Nov 6, 2023 | $8.06M | $6.51M | -19.17% | -$0.11 | -$0.07 | +36.36% | — | — |
| Q3 2023 Aug 3, 2023 | $6.33M | $3.33M | -47.47% | -$0.18 | -$0.21 | -16.67% | — | — |
| Q2 2023 May 11, 2023 | $1.85M | $1.68M | -9.35% | -$0.21 | -$0.23 | -9.52% | — | — |
| Q1 2023 Mar 30, 2023 | $740.00K | $1.53M | +107.43% | -$0.24 | -$0.26 | -8.33% | — | — |
| Q4 2022 Nov 11, 2022 | — | — | — | -$0.17 | -$0.31 | -82.35% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$0.10 | -$0.19 | -90.00% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.13 | -$0.14 | -7.69% | — | — |
| Q1 2022 Feb 28, 2022 | $50.00M | — | — | $3.52 | -$0.18 | -105.11% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.18 | -$0.16 | +11.11% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.19 | -$0.15 | +21.05% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.12 | -$0.18 | -50.00% | — | — |